ImpriMed, which builds AI-powered drug response prediction tech to help treat cancer in dogs and cats, raised a $23M Series A led by SoftBank Ventures Asia (Kate Park/TechCrunch)

Single Mother Loses Home After $53,000 Theft by Impostor Posing as Royal Bank Employee

Amazon’s Black Friday Deals: Unbeatable Prices on Levi’s Jeans

Unmissable Black Friday Deals on Premium Home Cinema at XGIMI

Title: Analyzing Deer Population: Are Hunter-Related Deaths in France Excessive? Insights from the Data

Chelsea Faces Heartbreak in “Game of the Century” Against Heidenheim: A Tale of Disappointment and Opportunity

Top Black Friday E-Bike Deals: Effortless Riding at the Push of a Button

Senate Endorses Surtax on Major Corporations and CMA CGM Tax on November 29, 2024 – Boursorama

Crypto Billionaire Joins Ranks of Switzerland’s Wealthiest: A New Era of Riches